Salvador Martín‐Algarra

Clinica Universidad de Navarra — Spain

Medicine · Health Sciences

40h-index11.6kcitations311works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(91), CAR-T cell therapy research(55), Cutaneous Melanoma Detection and Management(53), Melanoma and MAPK Pathways(51), Immunotherapy and Immune Responses(44)

Publications311 total

Title: Characterization of Melanoma of Unknown Primary in the Era of Immunotherapy and Targeted Therapy in Spain: Results from the Prospective Real World Study GEM 1801
Clinical & Translational Oncology·2025
Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801
Clinical & Translational Oncology·2025Open Access
Treatment outcomes in patients with advanced mucosal melanoma in Spain: results from the real-world GEM1801 study
Melanoma Research·2025
1635P Real-world outcomes after immunotherapy discontinuation in advanced melanoma: Insights from the GEM1801 study
Annals of Oncology·2025
Poor efficacy of anti PD-1 antibody based immunotherapy in patients with acral melanoma: results from the Spanish Melanoma Group (GEM) registry
Clinical & Translational Oncology·2025
Retreatment and rechallenge with BRAF/MEK inhibitors in patients with metastatic melanoma: results from the real-world Spanish Melanoma Registry (GEM-1801)
Clinical & Translational Oncology·2025· 2 cited
Quantifying Immune Checkpoint engagement in Patient Biopsies
2025Open Access
Neoadjuvant or perioperative therapy for melanoma metastasis in clinical practice: an international survey
The Lancet Oncology·2025· 3 cited
68P Real-world outcomes of nivolumab and/or ipilimumab in patients with stage III-IV melanoma, MELIOR study
Immuno-Oncology Technology·2024Open Access
Thyroid dysfunction caused by immune checkpoint inhibitors improves cancer outcomes
Endocrine Related Cancer·2024· 3 cited
Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis
Clinical & Translational Oncology·2024· 2 cited
Real-world effectiveness and safety of dabrafenib-trametinib as first-line of treatment for BRAF mutated metastatic melanoma: Results of the study GEM1801.
Journal of Clinical Oncology·2024
Access to melanoma drugs in Spain: a cross-sectional survey
Clinical & Translational Oncology·2024· 4 cited
1159P Characterization of melanoma of unknown primary in the era of immunotherapy and targeted therapy in Spain: Results from the prospective real-world study GEM 1801
Annals of Oncology·2023
1174P Sex differences in advanced melanoma in Spain: Results from the prospective real-world study GEM 1801
Annals of Oncology·2023· 2 citedOpen Access
Variation in response rates to isolated limb perfusion in different soft-tissue tumour subtypes: an international multi-centre study
European Journal of Cancer·2023· 12 citedOpen Access
Retreatment and rechallenge with BRAF/MEK inhibitors in patients with metastatic melanoma: Results from the observational study GEM1801.
Journal of Clinical Oncology·2023· 2 cited
Supplementary Table 1 from Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins
2023Open Access
Supplementary Figure 1A from Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins
2023Open Access
Supplementary Table 1 from Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins
2023Open Access
page 1 of 16Next →

Frequent Co-authors

José Luis Perez‐Gracia(9), Miguel F. Sanmamed(8), Álvaro González(8), María González‐Cao(8), Ignacio Melero(7), Enrique Espinosa(7), Carlos Alfaro(6), Axel Hauschild(5), María E. Rodríguez-Ruiz(5), Alfonso Gúrpide(5), José M. López-Picazo(5), Jean‐Jacques Grob(4), Lev Demidov(4), Michael Millward(4), Piotr Rutkowski(4), Wilson H. Miller(4), Bogusława Karaszewska(4), Cornelia Mauch(4), Vanna Chiarion‐Sileni(4), Patricia Haney(4)